A Study of the Efficacy of ABT-199 in Subjects With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia With the 17p Deletion

Clinical trial NCT01889186 · COMPLETED

Trial details

NCT number: NCT01889186
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia 17p Deletion Cancer of the Blood and Bone Marrow

Start date: 2013-06-27
Primary completion: 2020-10-28
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.